Skip to Main Content

Paper Details

Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
Mol Carcinog
10
2018
Author NameAffiliation
Ivan PasicPrincess Margaret Cancer Centre, University Health Network
Ivan PasicUniversity of Toronto
Osvaldo Espin-GarciaPrincess Margaret Cancer Centre, University Health Network
Osvaldo Espin-GarciaUniversity of Toronto
Yonathan BrhaneLunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Dangxiao ChengPrincess Margaret Cancer Centre, University Health Network
Zhuo ChenPrincess Margaret Cancer Centre, University Health Network
Wei XuPrincess Margaret Cancer Centre, University Health Network
Rayjean J HungLunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Geoffrey LiuPrincess Margaret Cancer Centre, University Health Network
Geoffrey LiuUniversity of Toronto
  • 1 - 11

Datasets

Release 1.2